Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The US Food and Drug Administration (FDA) has approved Cobenfy (Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. The drug targets cholinergic receptors as opposed to dopamine receptors, which has been the standard of care for more than 30…
English